PLRX financials
Pliant Therapeutics (PLRX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- PLRX revenue was $0.00 in fiscal 2025, net income -$149.34M.
PLRX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | – | -$156.37M | -$149.34M | -2.43 |
| 2024 | $0.00 | – | -$228.37M | -$210.30M | -3.47 |
| 2023 | $1.58M | – | -$184.15M | -$161.34M | -2.75 |
| 2022 | $9.69M | – | -$127.20M | -$123.32M | -2.94 |
| 2021 | $7.57M | – | -$97.53M | -$97.26M | -2.71 |
| 2020 | $41.82M | – | -$41.65M | -$41.53M | -1.95 |